{
  "paper_id": "PMC6731159",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731159/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Consort diagram indicating the total number of patients included in this analysis. The patients were women with clinically determined invasive luminal-like breast cancer from two study populations in Europe (the Polish Breast Cancer Study (PBCS) in Poland and the Study of Epidemiology and Risk Factors in Cancer Heredity (SEARCH) in the United Kingdom) with complete information on image analysis-based scores of ER, PR, HER2, and KI67, as well as other relevant clinicopathological and follow-up data",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/1bb7cc6d1178/41379_2019_270_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/1bb7cc6d1178/41379_2019_270_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/1bb7cc6d1178/41379_2019_270_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/1bb7cc6d1178/41379_2019_270_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/1bb7cc6d1178/41379_2019_270_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6731159/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/1bb7cc6d1178/41379_2019_270_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "Kaplan–Meier survival curves for the associations between a surrogate immunohistochemistry (IHC)-subtypes of luminal (A-like and B-like) breast cancer and b quartiles (Q1–Q4) of the IHC4-score with 10-year breast cancer-specific survival overall",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/11632c08f59d/41379_2019_270_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/11632c08f59d/41379_2019_270_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/11632c08f59d/41379_2019_270_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/11632c08f59d/41379_2019_270_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/11632c08f59d/41379_2019_270_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6731159/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/11632c08f59d/41379_2019_270_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3.",
      "caption": "Kaplan–Meier survival curves for the associations between quartiles (Q1–Q4) of the IHC4-score and 10-year breast cancer-specific survival in node-negative (a) and node-positive (b) luminal-like breast cancer patients",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/b8dd5f3202c4/41379_2019_270_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/b8dd5f3202c4/41379_2019_270_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/b8dd5f3202c4/41379_2019_270_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/b8dd5f3202c4/41379_2019_270_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/b8dd5f3202c4/41379_2019_270_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6731159/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a8/6760649/b8dd5f3202c4/41379_2019_270_Fig3_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group\n\n                      \n\n                    \n                \n            \n        \n\n        \n\n\n\n\n\n    \n        \n            \n        \n    \n       \n              ACTIONS\n           \n               \n               \n                     \n                         \n                            \n                         \n                         View on publisher site\n                     \n               \n               \n               \n               \n                    \n                         \n                            \n                        \n                        PDF (1.6 MB)\n                    \n               \n               \n                \n               \n                   \n                        \n                            \n                        \n                       Cite\n                    \n               \n                \n               \n\n                        \n                            \n                                \n                            \n                            \n                                \n                            \n                            Collections\n                       \n               \n               \n                    \n                         \n                            \n                        \n                        Permalink\n                    \n                   \n\n\n    \n          PERMALINK\n          \n              \n              \n                  \n                    \n                  \n                  Copy\n              \n          \n    \n\n               \n           \n       \n     \n\n        \n            RESOURCES\n            \n                \n                    \n                        \n                            Similar articles\n                        \n                    \n                    \n                        \n                    \n                    \n                        \n                             Cited by other articles\n                        \n                    \n                    \n                          \n                    \n                    \n                        \n                            \n                                 Links to NCBI Databases\n                            \n                        \n                        \n                        \n                    \n                    \n                \n            \n        \n\n\n        On this pageAbstractIntroductionMaterials and MethodsResultsDiscussionSupplementary informationAcknowledgementsCompliance with ethical standardsFootnotesSupplementary informationReferencesAssociated Data\n    \n\n\n\n        \n\n\n    \n        \n            Cite\n             \n                \n                    \n                \n             \n        \n\n        \n\n\n  \n  \n      \n        \n            \n                \n            \n            Copy\n        \n      \n      \n          \n                \n                    \n                \n                Download .nbib\n                .nbib\n            \n      \n      \n          \n\n\n  Format:\n  \n    \n      \n        AMA\n      \n    \n      \n        APA\n      \n    \n      \n        MLA\n      \n    \n      \n        NLM\n      \n    \n  \n\n      \n  \n\n        \n        \n        \n      \n    \n\n\n        \n  \n   \n        Add to Collections\n    \n    \n      \n\n\n\n\n    \n\n    \n        \n            \n            Create a new collection\n        \n        \n            \n            Add to an existing collection\n        \n    \n\n    \n        \n           \n                Name your collection\n               *\n          \n          \n        \n        \n             \n                Choose a collection\n              \n              \n              \n              \n                Unable to load your collection due to an error\n                Please try again\n              \n        \n    \n\n    \n        \n          Add\n        \n        \n          Cancel.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group\n\n                      \n\n                    \n                \n            \n        \n\n        \n\n\n\n\n\n    \n        \n            \n        \n    \n       \n              ACTIONS\n           \n               \n               \n                     \n                         \n                            \n                         \n                         View on publisher site\n                     \n               \n               \n               \n               \n                    \n                         \n                            \n                        \n                        PDF (1.6 MB)\n                    \n               \n               \n                \n               \n                   \n                        \n                            \n                        \n                       Cite\n                    \n               \n                \n               \n\n                        \n                            \n                                \n                            \n                            \n                                \n                            \n                            Collections\n                       \n               \n               \n                    \n                         \n                            \n                        \n                        Permalink\n                    \n                   \n\n\n    \n          PERMALINK\n          \n              \n              \n                  \n                    \n                  \n                  Copy\n              \n          \n    \n\n               \n           \n       \n     \n\n        \n            RESOURCES\n            \n                \n                    \n                        \n                            Similar articles\n                        \n                    \n                    \n                        \n                    \n                    \n                        \n                             Cited by other articles\n                        \n                    \n                    \n                          \n                    \n                    \n                        \n                            \n                                 Links to NCBI Databases\n                            \n                        \n                        \n                        \n                    \n                    \n                \n            \n        \n\n\n        On this pageAbstractIntroductionMaterials and MethodsResultsDiscussionSupplementary informationAcknowledgementsCompliance with ethical standardsFootnotesSupplementary informationReferencesAssociated Data\n    \n\n\n\n        \n\n\n    \n        \n            Cite\n             \n                \n                    \n                \n             \n        \n\n        \n\n\n  \n  \n      \n        \n            \n                \n            \n            Copy\n        \n      \n      \n          \n                \n                    \n                \n                Download .nbib\n                .nbib\n            \n      \n      \n          \n\n\n  Format:\n  \n    \n      \n        AMA\n      \n    \n      \n        APA\n      \n    \n      \n        MLA\n      \n    \n      \n        NLM\n      \n    \n  \n\n      \n  \n\n        \n        \n        \n      \n    \n\n\n        \n  \n   \n        Add to Collections\n    \n    \n      \n\n\n\n\n    \n\n    \n        \n            \n            Create a new collection\n        \n        \n            \n            Add to an existing collection\n        \n    \n\n    \n        \n           \n                Name your collection\n               *\n          \n          \n        \n        \n             \n                Choose a collection\n              \n              \n              \n              \n                Unable to load your collection due to an error\n                Please try again\n              \n        \n    \n\n    \n        \n          Add\n        \n        \n          Cancel.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group\n\n                      \n\n                    \n                \n            \n        \n\n        \n\n\n\n\n\n    \n        \n            \n        \n    \n       \n              ACTIONS\n           \n               \n               \n                     \n                         \n                            \n                         \n                         View on publisher site\n                     \n               \n               \n               \n               \n                    \n                         \n                            \n                        \n                        PDF (1.6 MB)\n                    \n               \n               \n                \n               \n                   \n                        \n                            \n                        \n                       Cite\n                    \n               \n                \n               \n\n                        \n                            \n                                \n                            \n                            \n                                \n                            \n                            Collections\n                       \n               \n               \n                    \n                         \n                            \n                        \n                        Permalink\n                    \n                   \n\n\n    \n          PERMALINK\n          \n              \n              \n                  \n                    \n                  \n                  Copy\n              \n          \n    \n\n               \n           \n       \n     \n\n        \n            RESOURCES\n            \n                \n                    \n                        \n                            Similar articles\n                        \n                    \n                    \n                        \n                    \n                    \n                        \n                             Cited by other articles\n                        \n                    \n                    \n                          \n                    \n                    \n                        \n                            \n                                 Links to NCBI Databases\n                            \n                        \n                        \n                        \n                    \n                    \n                \n            \n        \n\n\n        On this pageAbstractIntroductionMaterials and MethodsResultsDiscussionSupplementary informationAcknowledgementsCompliance with ethical standardsFootnotesSupplementary informationReferencesAssociated Data\n    \n\n\n\n        \n\n\n    \n        \n            Cite\n             \n                \n                    \n                \n             \n        \n\n        \n\n\n  \n  \n      \n        \n            \n                \n            \n            Copy\n        \n      \n      \n          \n                \n                    \n                \n                Download .nbib\n                .nbib\n            \n      \n      \n          \n\n\n  Format:\n  \n    \n      \n        AMA\n      \n    \n      \n        APA\n      \n    \n      \n        MLA\n      \n    \n      \n        NLM\n      \n    \n  \n\n      \n  \n\n        \n        \n        \n      \n    \n\n\n        \n  \n   \n        Add to Collections\n    \n    \n      \n\n\n\n\n    \n\n    \n        \n            \n            Create a new collection\n        \n        \n            \n            Add to an existing collection\n        \n    \n\n    \n        \n           \n                Name your collection\n               *\n          \n          \n        \n        \n             \n                Choose a collection\n              \n              \n              \n              \n                Unable to load your collection due to an error\n                Please try again\n              \n        \n    \n\n    \n        \n          Add\n        \n        \n          Cancel.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \n\nArticles from Modern Pathology are provided here courtesy of Nature Publishing Group.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Given the prognostic strength of the PREDICT-score that we observed, further studies will be needed to determine whether combining the IHC4-score and PREDICT-score will provide superior prognostic information than PREDICT-score plus HER2 and KI67.Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif) \nAcknowledgements\nMD acknowledges support from the Royal Marsden NIHR Biomedical Research Center.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The analysis comprised of women with luminal-like, i.e., ER + and/or PR + tumors and for whom we also had complete data on image analysis-based scores for ER, PR, HER2, and KI67 (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Clinicopathological characteristics of participants in the Polish and SEARCH study populations and overall\n\n\n\n\nStudy population\n\n\n\nOverall (N = 2498)\nPolish study (N = 558)\nSEARCH study (N = 1940)\n\n\n\nCharacteristic\n\nN\n\n%\n\nN\n\n%\n\nN\n\n%\n\nP-value*\n\n\n\nAge at diagnosis, years\n\n  <35\n41\n1.6\n3\n0.5\n38\n2.0\n<0.001\n\n\n  35–50\n804\n32.2\n148\n26.5\n656\n33.8\n\n\n\n  50–65\n1342\n53.7\n272\n48.7\n1070\n55.2\n\n\n\n  >65\n311\n12.4\n135\n24.2\n176\n9.1\n\n\nGrade\n\n  Low\n590\n26.1\n148\n26.5\n442\n26.0\n<0.001\n\n\n  Intermediate\n1259\n55.7\n342\n61.3\n917\n53.8\n\n\n\n  High\n412\n18.2\n68\n12.2\n344\n20.2\n\n\nStage\n\n  I\n1168\n48.9\n233\n48.8\n935\n48.9\n0.45\n\n\n  II\n1154\n48.3\n231\n48.4\n923\n48.3\n\n\n\n  III\n50\n2.1\n12\n2.5\n38\n2.0\n\n\n\n  IV\n17\n0.7\n1\n0.2\n16\n0.8\n\n\nMorphology\n\n  Ductal\n1632\n68.6\n281\n50.3\n1351\n74.2\n<0.001\n\n\n  Lobular\n464\n19.5\n121\n21.7\n343\n18.8\n\n\n\n  Othera\n\n284\n11.9\n156\n28.0\n128\n7.0\n\n\nSize\n\n  <2 cm\n1571\n65.5\n331\n59.3\n1240\n67.4\n0.002\n\n\n  2–5 cm\n770\n32.1\n210\n37.6\n560\n30.4\n\n\n\n  >5 cm\n58\n2.4\n17\n3.0\n41\n2.2\n\n\nNode status\n\n  Negative\n1370\n60.9\n308\n56.0\n1062\n62.5\n0.007\n\n\n  Positive\n880\n39.1\n242\n44.0\n638\n37.5\n\n\nBreast cancer subtype\n\n  Luminal A-like\n1198\n55.7\n206\n38.0\n992\n61.7\n\n\n\n  Luminal B-like\n951\n44.3\n336\n62.0\n615\n38.3\n<0.001\n\nEndocrine therapy\n\n  No\n394\n19.6\n191\n35.6\n203\n13.8\n<0.001\n\n\n  Yes\n1614\n80.4\n346\n64.4\n1268\n86.2\n\n\n\n\nOpen in a new tab\n\n*P-values were from chi-square tests comparing the distributions of the clinicopathological characteristics between the two study populations\naIn the Polish study, “Other” morphology comprised invasive ductal carcinoma with lobular carcinomatous components (71%), tubular carcinoma (18%), infiltrating papillary carcinoma (7%), and mucinous adenocarcinoma (4%) while in the SEARCH study, the majority (58%) were invasive ductal carcinoma with lobular carcinomatous components, mucinous carcinoma (15%), cribriform carcinoma (13%), adenocarcinoma (not otherwise specified) (9%), and Medullary carcinoma (5%)\nDynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Dynamic range of image analysis-based scores for immunohistochemistry markers in the IHC4-score\nImage analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Image analysis produced quantitative scores (0–100%) for each of the three nuclear markers (Supplementary Fig. 1) with median (standard deviation) scores of 62% (34), 57% (38), and 9% (11) for ER, PR, and KI67, respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "When combined with data on HER2 in the IHC4 algorithm, these markers produced an IHC4-score with a dynamic range of −148 to 289 (mean = 33, standard deviation = 65; Supplementary Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The distribution of the IHC4-score differed by study population, with patients from the Polish study generally having higher values than those from the SEARCH study population (Supplementary Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Associations between Subtype, IHC4-score, C-score, and PREDICT-score with 10-year breast cancer-specific survival\nIn Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In Kaplan–Meier curves (Fig. 2) and in univariable models (Table 2), Subtype (luminal B-like vs. A-like) [hazard ratio (95% confidence interval) = 1.64 (1.25–2.14); P-value < 0.001] and IHC4-score [hazard ratio (95% confidence interval)/1 standard deviation = 1.32 (1.20–1.44); P-value < 0.001] were significantly associated with survival overall.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further, when we performed analyses stratified by lymph-nodal involvement, higher values of the IHC4-score were associated with worse breast cancer-specific survival in women with node-negative (Fig. 3a; logrank P-value = 0.002) and node-positive (Fig. 3b; logrank P-value = 0.002) disease.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We observed an overlap in the distribution of the IHC4-score between luminal A-like and B-like subtypes, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, by comparing women with IHC4-score above the mean + 1 standard deviation (denoted as high IHC4-score) with those that had scores below this threshold (low IHC4-score), we observed those with high IHC4-score to have significantly worse survival outcomes than those with low scores, overall and in both study populations (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Supplementary information\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 1 (16.6KB, docx).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 1 (16.6KB, docx).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 1 (16.6KB, docx).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 2 (508.1KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 2 (508.1KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 2 (508.1KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Materials\n\nSupplementary Table 1 (13.1KB, docx) \n\nSupplementary Figure 1 (16.6KB, docx) \n\nSupplementary Figure 2 (508.1KB, tif) \n\nOPEN ACCESS APC FORM (530.6KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 1 (16.6KB, docx).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 1 (16.6KB, docx).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 1 (16.6KB, docx).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 2 (508.1KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 2 (508.1KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Supplementary Figure 2 (508.1KB, tif).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 3,
    "claims_count": 111,
    "images_downloaded": 3,
    "tables_filtered": 4
  }
}